AFL
66
2
NUE
40
-3
EL
55
-3
MS
70
-2
HAL
50
4
TJX
58
-3
IFF
69
13
ZION
55
2
FRT
53
3
NKE
39
2
BWA
61
-7
CSX
39
-4
GIS
58
-2
CF
44
-3
URI
63
3
UPS
51
-2
CMCSA
55
-2
PEG
55
2
STI
15
-5
FLS
75
8
AFL
66
2
NUE
40
-3
EL
55
-3
MS
70
-2
HAL
50
4
TJX
58
-3
IFF
69
13
ZION
55
2
FRT
53
3
NKE
39
2
BWA
61
-7
CSX
39
-4
GIS
58
-2
CF
44
-3
URI
63
3
UPS
51
-2
CMCSA
55
-2
PEG
55
2
STI
15
-5
FLS
75
8
Financhill
Back

Cytek Biosciences Stock Predictions

Sell
16

CTKB
Cytek Biosciences

Last Price:
6.10
Seasonality Move:
42.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Cytek Biosciences Stock Forecast

  • Over the next 52 weeks, Cytek Biosciences has on average historically fallen by 18.9% based on the past 2 years of stock performance.
  • Cytek Biosciences has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Cytek Biosciences Stock Undervalued?
    The current Cytek Biosciences [CTKB] share price is $6.10. The Score for CTKB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CTKB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Cytek Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Cytek Biosciences has on average historically fallen by 18.9% based on the past 2 years of stock performance.

Cytek Biosciences Stock Rating

Sell
16
Cytek Biosciences (CTKB) is a Sell

Is Cytek Biosciences overpriced?

  • Cytek Biosciences has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Cytek Biosciences Stock Price History

Is CTKB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTKB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
cytekbio.com

52-Week Data

52-Week High:
9.87
52-Week Low:
3.80

Prediction Charts

Market Cap:
800.76M
Price in USD:
6.10
Volume:
560.86K
Beta:
1.42

Technical Analysis

SMA50:
6.36
SMA100:
7.37
SMA200:
7.03
52-Wk Change:
-11.08%

Stock Predictions

  • Is Cytek Biosciences stock public?
    Yes, Cytek Biosciences is a publicly traded company.
  • What is the Cytek Biosciences stock quote today?
    The Cytek Biosciences stock price is 6.10 USD today.
  • How to buy Cytek Biosciences stock online?
    You can buy Cytek Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 5.93 6.01 6.14 5.88
May-1 5.98 6.37 6.55 5.88
May-2 6.46 6.20 6.48 6.18
May-3 6.41 6.22 6.41 6.07
May-6 6.30 6.42 6.46 6.27
May-7 6.42 6.38 6.45 6.23
May-8 6.28 6.27 6.35 6.24
May-9 6.35 6.20 6.56 6.07
May-10 6.24 6.30 6.62 6.13
May-13 6.30 6.18 6.43 6.09
May-14 6.32 6.30 6.44 6.24
May-15 6.35 6.10 6.39 6.08
May-16 6.07 6.18 6.28 6.05
May-17 6.17 6.10 6.26 5.91

Cytek Biosciences Earnings

Cytek Biosciences Earnings Report: Per Share Cytek Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytek Biosciences Forecast Revenue Growth

Cytek Biosciences Stock Analysis: Historical quarterly revenues per share for Cytek Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.06 per share, and an increase next year of $0.08 per share.

* Cytek Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.